Gentian Diagnostics ASA (OSL:GENT)
54.80
-0.20 (-0.36%)
Dec 5, 2025, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 845.14 million as of December 5, 2025. Its market cap has increased by 33.01% in one year.
Market Cap
845.14M
Enterprise Value
760.42M
Revenue
172.52M
Ranking
n/a
PE Ratio
19.93
Stock Price
54.80
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 845.14M, an increase of 191.81%. That is a compound annual growth rate of 12.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.59B |
| Nordhealth AS | 2.91B |
| Photocure ASA | 1.69B |
| Thor Medical ASA | 1.45B |
| ArcticZymes Technologies ASA | 1.10B |
| Omda AS | 953.61M |
| Vistin Pharma ASA | 880.24M |
| Nykode Therapeutics AS | 762.81M |